Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-11

Clinical Trial Update: A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of PF-00489791 in adults with mild to moderate hypertension has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-00489791 (PF-00489791)

Snippet

Sponsor: Pfizer | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-10-11